STOCK TITAN
  1. Home
  2. Sec-filings
  3. EVAX
  4. [6-K] – Evaxion A/S (EVAX) (CIK 0001828253)

[6-K] – Evaxion A/S (EVAX) (CIK 0001828253)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock EVAX logo
Evaxion AS

NASDAQ:EVAX

EVAX Rankings

#5582 Ranked by Market Cap
N/A Ranked by Dividends
#71 Top Gainer

EVAX Latest News

Oct 13, 2025
Evaxion to present a breadth of data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025
Oct 8, 2025
Evaxion expands AI-Immunology™ platform with automated vaccine design module
Oct 3, 2025
Evaxion to present new biomarker data for AI-designed personalized cancer vaccine EVX-01 at the SITC 2025 Annual Meeting
Sep 25, 2025
Evaxion out-licenses vaccine candidate EVX-B3 to MSD
Aug 27, 2025
Evaxion to present at several conferences during the second half of 2025

EVAX Latest SEC Filings

Oct 8, 2025
[6-K] Evaxion A/S Current Report (Foreign Issuer)
Oct 6, 2025
[6-K] Evaxion A/S Current Report (Foreign Issuer)
Sep 25, 2025
[6-K] Evaxion A/S Current Report (Foreign Issuer)
Aug 27, 2025
[6-K] Evaxion A/S American Depositary Share Current Report (Foreign Issuer)
Aug 14, 2025
[6-K] Evaxion A/S American Depositary Share Current Report (Foreign Issuer)

EVAX Stock Data

37.27M
4.86M
23.07%
6.82%
1.91%
Biotechnology
Healthcare
Link
Denmark
Horsholm